CNBX Cnbx Pharmaceuticals Inc.
Fundamentals / CIK 0001343009 / USDCnbx Pharmaceuticals Inc. reported $0 in revenue and a net loss of $462K for the trailing twelve months ended May 31, 2026 (down 100.0% year over year).
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CNBX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$0 -100.0% YoY
-
Operating Income TTM-$429K Operating profit
-
Net Income TTM-$462K GAAP bottom line
-
Diluted EPS TTM-$0.00 Split-adjusted
-
Free Cash Flow TTM-- Operating CF less CapEx
-
Cash & ST Investments May 31, 2026$9.5K Total debt: $120K
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $130K | $410K | $30K | $0 | $7.2K | $9.8K | $9.6K | $5.7K | $112K |
| Gross Profit | -- | -- | -- | -- | -- | -- | -- | -- | $5.7K | $112K |
| Research & Development | $0 | $195K | $432K | $1.18M | $1.77M | $1.68M | $1.54M | $1.00M | $247K | $178K |
| Selling, General & Admin | -- | -- | -- | -- | $849K | $1.37M | $1.77M | $2.81M | $1.61M | $216K |
| Total Operating Expenses | $272K | $713K | $1.34M | $2.98M | $2.60M | $3.05M | $3.31M | $3.82M | $1.86M | $393K |
| Operating Income | -$272K | -$583K | -$931K | -$2.95M | -$2.60M | -$3.04M | -$3.30M | -$3.81M | -$1.85M | -$281K |
| EBITDA | -$272K | -$511K | -$769K | -$2.76M | -$2.38M | -$2.83M | -$3.11M | -$3.72M | -$1.85M | -$279K |
| Interest Expense | $40K | -- | -- | -- | -- | -- | -- | $852 | $4.4K | $7.2K |
| Net Income | -$314K | -$695K | -$3.71M | -$3.72M | -$3.19M | -$7.47M | $1.13M | -$3.78M | -$1.93M | -$307K |
| Basic EPS | $0.00 | -$0.02 | -$0.42 | -$3.59 | -$2.41 | -$12.05 | $2.41 | -$3.73 | -$2.17 | $0.00 |
| Diluted EPS | $0.00 | -$0.02 | -$0.42 | -$3.59 | -$2.41 | -$12.05 | $2.41 | -$3.73 | -$2.17 | $0.00 |
| Basic Shares Outstanding | 90.6M | 30.2M | 8.8M | 1.2M | 1.1M | 1.1M | 1.1M | 999.1K | 916.2K | 857.0K |
| Diluted Shares Outstanding | 90.6M | 30.2M | 8.8M | 1.2M | 1.1M | 1.1M | 1.1M | 999.1K | 916.2K | 857.0K |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-05-31 | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 | 2025-02-28 | 2024-11-30 | 2024-08-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of Revenue | $0 | $0 | -- | -- | $0 | $0 | -- | -- |
| Gross Profit | $0 | $0 | -- | -- | $0 | $0 | -- | -- |
| Research & Development | -- | $0 | $0 | $0 | $0 | $0 | $0 | -$74K |
| Total Operating Expenses | $163K | $73K | $64K | $130K | $40K | $65K | $37K | $53K |
| Operating Income | -$163K | -$73K | -$64K | -$130K | -$40K | -$65K | -$37K | -$53K |
| EBITDA | -- | -- | -$64K | -$130K | -$40K | -$65K | -$37K | -$53K |
| Interest Expense | -- | -$33K | $46K | $18K | $14K | $4.2K | $3.1K | -- |
| Net Income | -$154K | -$44K | -$114K | -$150K | -$60K | -$70K | -$34K | -$61K |
| Basic EPS | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 | -$0.00 | -- |
| Diluted EPS | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 | -$0.00 | -- |
| Basic Shares Outstanding | 1.32B | 931.0M | 732.9M | -- | 42.6M | 32.1M | 31.1M | -- |
| Diluted Shares Outstanding | 1.32B | 931.0M | 732.9M | -- | 42.6M | 32.1M | 31.1M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $15K | $26K | $130K | $118K | $1.39M | $778K | $266K | $1.39M | $1.39M | $19K |
| Short-Term Investments | -- | -- | -- | -- | -- | $0 | $3.26M | $0 | -- | -- |
| Cash & Short-Term Investments | $15K | $26K | $130K | $118K | $1.39M | $778K | $3.52M | $1.39M | $1.39M | $19K |
| Total Current Assets | $18K | $31K | $224K | $198K | $1.59M | $930K | $4.31M | $1.62M | $3.52M | $22K |
| Property, Plant & Equipment, Net | $0 | $0 | $275K | $437K | $643K | $863K | $1.00M | $974K | $120K | $1.6K |
| Total Non-Current Assets | $0 | $0 | $275K | $613K | $1.49M | $1.29M | $10.88M | $1.56M | $120K | $1.6K |
| Total Assets | $18K | $31K | $499K | $811K | $3.08M | $2.22M | $15.18M | $3.18M | $3.64M | $24K |
| Short-Term Debt | $0 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Current Liabilities | $2.51M | $2.51M | $2.52M | $2.44M | $1.27M | $455K | $439K | $539K | $699K | $491K |
| Total Non-Current Liabilities | $0 | $0 | $0 | -- | $0 | $0 | $0 | $0 | $5.88M | $0 |
| Total Liabilities | $2.51M | $2.51M | $2.52M | -- | $1.27M | $455K | $439K | $539K | $6.58M | $491K |
| Total Debt (incl. Leases) | $0 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Common Stock | $55K | $3.1K | $2.3K | $124 | $14K | $14K | $13K | $12K | $12K | $11K |
| Retained Earnings | -$25.27M | -$24.95M | -$24.26M | -$20.55M | -$16.83M | -$13.63M | -$6.16M | -$7.30M | -$3.52M | -$1.59M |
| Accumulated Other Comp. Income | $0 | $0 | $0 | -$2.57M | -$1.91M | -$2.77M | $2.81M | $0 | -- | -- |
| Total Stockholders' Equity | -$2.50M | -$2.48M | -$2.02M | $1.63M | $1.81M | $1.76M | $14.74M | $2.65M | -$2.94M | -$467K |
| Total Equity | -$2.50M | -$2.48M | -$2.02M | $1.63M | $1.81M | $1.76M | $14.74M | $2.65M | -$2.94M | -$467K |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-05-31 | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 | 2025-02-28 | 2024-11-30 | 2024-08-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $9.5K | $12K | $7.7K | $15K | $14K | $46K | $17K | $26K |
| Cash & Short-Term Investments | $9.5K | $12K | $7.7K | $15K | $14K | $46K | $17K | $26K |
| Total Current Assets | $13K | $15K | $11K | $18K | $19K | $51K | $22K | $31K |
| Property, Plant & Equipment, Net | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $13K | $15K | $11K | $18K | $19K | $51K | $22K | $31K |
| Short-Term Debt | $120K | $75K | -- | $0 | -- | -- | -- | -- |
| Total Current Liabilities | $2.67M | $2.55M | $2.58M | $2.51M | $2.56M | $2.62M | $2.54M | $2.51M |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $2.67M | $2.55M | $2.58M | $2.51M | $2.56M | $2.62M | $2.54M | $2.51M |
| Total Debt (incl. Leases) | $120K | $75K | -- | $0 | -- | -- | -- | -- |
| Common Stock | $148K | $113K | $75K | $55K | $9.3K | $3.4K | $3.1K | $3.1K |
| Retained Earnings | -$25.58M | -$25.43M | -$25.38M | -$25.27M | -$25.12M | -$25.06M | -$24.99M | -$24.95M |
| Accumulated Other Comp. Income | $0 | $0 | -- | $0 | -- | $0 | -- | $0 |
| Total Stockholders' Equity | -$2.66M | -$2.53M | -$2.57M | -$2.50M | -$2.54M | -$2.57M | -$2.51M | -$2.48M |
| Total Equity | -$2.66M | -$2.53M | -$2.57M | -$2.50M | -$2.54M | -$2.57M | -$2.51M | -$2.48M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$314K | -$695K | -$3.71M | -$3.72M | -$3.19M | -$7.47M | $4.36M | $0 | -$1.93M | -$307K |
| Depreciation & Amortization | $0 | $72K | $162K | $199K | $221K | $215K | $189K | $88K | $7.0K | $1.6K |
| Stock-Based Compensation | $0 | $140K | $180K | $729K | $0 | $72K | $247K | $1.85M | $881K | $30K |
| Operating Cash Flow | -$171K | -$244K | -$113K | -$1.68M | -$2.49M | -$2.77M | -$3.09M | -$1.97M | -$864K | -$120K |
| Investing Cash Flow | $0 | $113K | $25K | $25K | $645K | $3.29M | -$5.25M | -$1.44M | -$126K | $0 |
| Common Stock Issued | -- | -- | -- | -- | -- | $0 | $7.29M | $1.55M | $4.41M | $94K |
| Financing Cash Flow | $160K | $28K | $100K | $390K | $2.46M | $0 | $7.22M | $1.44M | $4.34M | $114K |
| Net Change in Cash | -$11K | -$103K | $12K | -$1.26M | $609K | $512K | -$1.13M | -$1.97M | $3.35M | -$6.1K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-05-31 | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 | 2025-02-28 | 2024-11-30 | 2024-08-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$154K | -$44K | -$114K | -$150K | -$60K | -$70K | -$34K | -$61K |
| Depreciation & Amortization | -- | -- | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | -- | -- | $0 | $0 | $0 | $0 | $0 | $35K |
| Operating Cash Flow | -$48K | -$31K | -$47K | -$29K | -$52K | -$52K | -$39K | -$48K |
| Investing Cash Flow | -- | -- | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | $30K | -- |
| Financing Cash Flow | $45K | $35K | $40K | $30K | $20K | $80K | $30K | $1.3K |
| Net Change in Cash | -$2.7K | $4.5K | -$7.4K | -- | -$32K | $28K | -$9.1K | -- |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -- | -- | -- | -- | -- | -- | -- | -- | 100.0% | 100.0% |
| Operating Margin | -- | -448.3% | -227.1% | -9860.4% | -- | -42524.1% | -33563.0% | -39670.1% | -32616.1% | -249.5% |
| Net Profit Margin | -- | -534.5% | -904.6% | -12428.2% | -- | -104337.9% | 11510.4% | -39335.7% | -34022.5% | -273.0% |
| Return on Equity (ROE) | -- | -- | -- | -228.1% | -176.9% | -423.2% | 7.7% | -142.8% | -- | -- |
| Return on Assets (ROA) | -1703.0% | -2215.2% | -743.5% | -459.0% | -103.8% | -336.5% | 7.5% | -118.6% | -53.2% | -1295.2% |
| Current Ratio | 0.01x | 0.01x | 0.09x | 0.08x | 1.25x | 2.04x | 9.81x | 3.01x | 5.03x | 0.04x |
| Quick Ratio | 0.01x | 0.01x | 0.05x | 0.05x | 1.09x | 1.71x | 8.03x | 2.58x | 1.99x | 0.04x |
| Revenue Growth (YoY) | -100.0% | -68.3% | +1269.1% | -- | -100.0% | -27.3% | +2.5% | +68.9% | -94.9% | -- |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -- | -94.9% | -- |
| Net Income Growth (YoY) | -- | -- | -- | -- | -- | -759.1% | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -600.0% | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | -100.0% | -52.0% | +383.7% | +294.9% | -100.0% | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -- | -102.2% | -- | -- | -- | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-05-31 | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 | 2025-02-28 | 2024-11-30 | 2024-08-31 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -- | -- | -- | -- | -- | -- | -1102.6% | -448.3% |
| Net Profit Margin | -- | -- | -- | -- | -- | -- | -1356.0% | -534.5% |
| Return on Assets (ROA) | -3611.5% | -2467.6% | -3523.9% | -1703.0% | -1205.8% | -583.0% | -2470.1% | -2215.2% |
| Current Ratio | 0.00x | 0.01x | 0.00x | 0.01x | 0.01x | 0.02x | 0.01x | 0.01x |
| Quick Ratio | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | 0.02x | 0.01x | 0.01x |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | -100.0% | -100.0% | -100.0% |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -- | -100.0% | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -23219.6% | -- | -- | -335.2% |